在儿科骨髓瘤中减强多克索鲁比剂量,更少更好吗?
Hadeel Halalsheh1,2, Ramiz Abu-Hijlih3, Taleb Ismael1
1Department of Pediatrics, King Hussein Cancer Center, Amman, Jordan.
South Asian journal of cancer
|December 4, 2023
概括
在骨髓瘤治疗中降低多克索鲁比剂量可能提供足够的疾病控制,心脏毒性降低. 这种方法可能对心力衰竭管理资源有限的发展中国家有益.
科学领域:
- 儿科瘤学 儿科瘤学
- 心血管毒理学心血管毒理学
- 化疗疗方案 化疗方案
背景情况:
- 骨髓瘤治疗指南通常涉及高累积剂量的多克索鲁比辛.
- 对多克索鲁比诱导的心脏毒性的担忧促使对剂量降级进行了调查.
- 2009年实施新的临床实践指南 (CPG),旨在标准化骨髓瘤治疗.
研究的目的:
- 评估小儿骨髓瘤患者减少多克索鲁比辛累积剂量的疗效和安全性.
- 评估多克索鲁比辛剂量减强后的生存率和心脏事件.
- 为了确定修改后的化疗方案是否能够保持足够的疾病控制,同时最大限度地减少心脏毒性.
主要方法:
- 在2009年至2018年期间接受治疗的18岁以下骨髓瘤患者的回顾性队列研究.
- 患者接受了统一的CPG,并减少了375 mg/m2.2的累积多克索鲁比辛剂量.
- 计算了生存率 (无事件生存率和总生存率),并使用了日志等级测试进行比较.
主要成果:
- 79名患者接受了减少剂量的多克索鲁比治疗;中位数随访时间为43.3个月.
- 5年无事件生存率 (EFS) 为50%±5.9%,整体生存率 (OS) 为64%±5.7%.
- 对于非转移性四肢瘤 (n=56),五年EFS为60%±6.9%,OS为70%±6.8%. 化疗反应与更好的EFS和OS相关 (p<0.05). 只有两名患者经历过渡性心脏功能障碍.
结论:
- 减少多克索鲁比的强度可能为儿科骨髓瘤提供足够的疾病控制.
- 减少多克索鲁比辛治疗方案显示可接受的存活率与最小的心脏毒性.
- 这种方法对于资源有限的环境可能是一个可行的选择,考虑到心力衰竭的发病率较低.
相关概念视频
Renal Failure: Dose Adjustments
95
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
95
Dosage Regimen: Fixed Dose
1.9K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
1.9K
Rational Dosage Regimen: Maintenance Dose and Loading Dose
4.1K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.1K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K


